These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 8878553

  • 1. Proteasome-dependent regulation of p21WAF1/CIP1 expression.
    Blagosklonny MV, Wu GS, Omura S, el-Deiry WS.
    Biochem Biophys Res Commun; 1996 Oct 14; 227(2):564-9. PubMed ID: 8878553
    [Abstract] [Full Text] [Related]

  • 2. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB, Kislyakova TV, Aksenov ND, Osipov KA, Pospelov VA.
    Oncogene; 2000 Aug 10; 19(34):3858-65. PubMed ID: 10951579
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation.
    An WG, Chuman Y, Fojo T, Blagosklonny MV.
    Exp Cell Res; 1998 Oct 10; 244(1):54-60. PubMed ID: 9770348
    [Abstract] [Full Text] [Related]

  • 5. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
    Saied IT, Shamsuddin AM.
    Anticancer Res; 1998 Oct 10; 18(3A):1479-84. PubMed ID: 9673359
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D, Cannella D, Boulaire J, Fitzgerald P, Fotedar A, Fotedar R.
    Oncogene; 1999 Jul 29; 18(30):4313-25. PubMed ID: 10439039
    [Abstract] [Full Text] [Related]

  • 8. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation.
    Le NT, Richardson DR.
    Carcinogenesis; 2003 Jun 29; 24(6):1045-58. PubMed ID: 12807743
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
    Han C, Demetris AJ, Michalopoulos GK, Zhan Q, Shelhamer JH, Wu T.
    Hepatology; 2003 Jul 29; 38(1):167-77. PubMed ID: 12829999
    [Abstract] [Full Text] [Related]

  • 11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 29; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 12. Role of p53 in aziridinylbenzoquinone-induced p21waf1 expression.
    Wu RC, Hohenstein A, Park JM, Qiu X, Mueller S, Cadenas E, Schönthal AH.
    Oncogene; 1998 Jul 23; 17(3):357-65. PubMed ID: 9690517
    [Abstract] [Full Text] [Related]

  • 13. The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67.
    Wu Y, Luo H, Kanaan N, Wu J.
    J Cell Biochem; 2000 Jan 23; 76(4):596-604. PubMed ID: 10653979
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
    Ling YH, Liebes L, Jiang JD, Holland JF, Elliott PJ, Adams J, Muggia FM, Perez-Soler R.
    Clin Cancer Res; 2003 Mar 23; 9(3):1145-54. PubMed ID: 12631620
    [Abstract] [Full Text] [Related]

  • 15. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
    Gooch JL, Herrera RE, Yee D.
    Cell Growth Differ; 2000 Jun 23; 11(6):335-42. PubMed ID: 10910100
    [Abstract] [Full Text] [Related]

  • 16. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
    Kaneuchi M, Yamashita T, Shindoh M, Segawa K, Takahashi S, Furuta I, Fujimoto S, Fujinaga K.
    Mol Carcinog; 1999 Sep 23; 26(1):44-52. PubMed ID: 10487521
    [Abstract] [Full Text] [Related]

  • 17. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M, Husnjak K, Körbler T, Pavelić J.
    Cancer Gene Ther; 2003 Jun 23; 10(6):457-67. PubMed ID: 12768191
    [Abstract] [Full Text] [Related]

  • 18. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L, Sowa Y, Sakai T, Pardee AB.
    Oncogene; 2000 Nov 23; 19(50):5712-9. PubMed ID: 11126357
    [Abstract] [Full Text] [Related]

  • 19. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization.
    Kobayashi N, Takada Y, Hachiya M, Ando K, Nakajima N, Akashi M.
    Cytokine; 2000 Dec 23; 12(12):1745-54. PubMed ID: 11097743
    [Abstract] [Full Text] [Related]

  • 20. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J, Le HV, Massagué J.
    Nature; 2002 Oct 17; 419(6908):729-34. PubMed ID: 12384701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.